Duetact Side Effects & Drug Interactions

/Home/Diabetes Treatment/Diabetes Drug Treatment/Duetact (glimepiride and pioglitazone)/Duetact Side Effects

Duetact Side Effects & Drug Interactions

SIDE EFFECTS
The adverse events reported in at least 5% of patients in the controlled 16-week clinical studies between placebo plus a sulfonylurea and pioglitazone (15 mg and 30 mg combined) plus sulfonylurea-treatment arms were upper respiratory tract infection (15.5% and 16.6%), accidental injury (8.6% and 3.5%) and combined edema/peripheral edema (2.1% and 7.2%), respectively.

The incidence and type of adverse events reported in at least 5% of patients in any combined treatment group from the 24-week study comparing pioglitazone 30 mg plus a sulfonylurea and pioglitazone 45 mg plus a sulfonylurea are shown in Table 4; the rate of adverse events resulting in study discontinuation between the two treatment groups was 6.0% and 9.7%, respectively.

Please visit the website for more information.

WebMD
111 8th Ave
7th Floor
New York, NY 10011
T: (212) 624-3700

Copyright © 2008 by RxList Inc.